DK166763C - Immunoglobulin-g-holdig fraktion - Google Patents

Immunoglobulin-g-holdig fraktion

Info

Publication number
DK166763C
DK166763C DK132284A DK132284A DK166763C DK 166763 C DK166763 C DK 166763C DK 132284 A DK132284 A DK 132284A DK 132284 A DK132284 A DK 132284A DK 166763 C DK166763 C DK 166763C
Authority
DK
Denmark
Prior art keywords
detectable
animals
dose
average
body weight
Prior art date
Application number
DK132284A
Other languages
Danish (da)
English (en)
Other versions
DK132284A (da
DK166763B1 (da
DK132284D0 (da
Inventor
Johann Eibl
Yendra Linnau
Otto Schwarz
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25594348&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK166763(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AT0092983A external-priority patent/AT383737B/de
Priority claimed from AT0093083A external-priority patent/AT383738B/de
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of DK132284D0 publication Critical patent/DK132284D0/da
Publication of DK132284A publication Critical patent/DK132284A/da
Application granted granted Critical
Publication of DK166763C publication Critical patent/DK166763C/da
Publication of DK166763B1 publication Critical patent/DK166763B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK132284A 1983-03-16 1984-02-29 Immunoglobulin-g-holdig fraktion DK166763B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AT92983 1983-03-16
AT0092983A AT383737B (de) 1983-03-16 1983-03-16 Verfahren zur verwendung einer immunoglobulin-g enthaltenden fraktion
AT0093083A AT383738B (de) 1983-03-16 1983-03-16 Verfahren zur verwendung einer immunglobulin-g enthaltenden fraktion
AT93083 1983-03-16

Publications (4)

Publication Number Publication Date
DK132284D0 DK132284D0 (da) 1984-02-29
DK132284A DK132284A (da) 1984-09-17
DK166763C true DK166763C (da) 1993-07-12
DK166763B1 DK166763B1 (da) 1993-07-12

Family

ID=25594348

Family Applications (1)

Application Number Title Priority Date Filing Date
DK132284A DK166763B1 (da) 1983-03-16 1984-02-29 Immunoglobulin-g-holdig fraktion

Country Status (7)

Country Link
US (1) US5122373A (fr)
EP (1) EP0122909B1 (fr)
JP (1) JPH0639388B2 (fr)
AT (1) ATE30034T1 (fr)
CA (1) CA1245155A (fr)
DE (1) DE3466542D1 (fr)
DK (1) DK166763B1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK166763B1 (da) * 1983-03-16 1993-07-12 Immuno Ag Immunoglobulin-g-holdig fraktion
GB8519848D0 (en) * 1985-08-07 1985-09-11 Schweiz Rotes Kreuz Treatment of chronic inflammatory disease
JPS6322243A (ja) * 1986-07-14 1988-01-29 Niigata Eng Co Ltd 位置決め装置
US5553590A (en) * 1992-07-14 1996-09-10 Yamaha Hatsudoki Kabushiki Kaisha Intake control valve
DE4344824C1 (de) * 1993-12-28 1995-08-31 Immuno Ag Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
GB9807781D0 (en) * 1998-04-09 1998-06-10 Univ Bristol Therapeutic agent
US20030096753A1 (en) * 1998-04-09 2003-05-22 Robertson Alan George Simpson Therapeutic agent
ES2158776B1 (es) * 1999-04-13 2002-03-16 Apc Europ S A Procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes.
GB0020504D0 (en) * 2000-08-18 2000-10-11 Univ Bristol Therapeutic method
GB0122400D0 (en) * 2001-09-17 2001-11-07 Univ Bristol Polypeptide purification method
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
AU2008286361B2 (en) 2007-08-13 2013-09-26 Takeda Pharmaceutical Company Limited IVIG modulation of chemokines for treatment of multiple sclerosis, Alzheimer's disease, and Parkinson's disease
TWI489994B (zh) 2008-03-17 2015-07-01 Baxter Healthcare Sa 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
MX2011012576A (es) 2009-05-27 2012-05-08 Baxter Int Metodo para producir una preparacion altamente concentrada de inmunoglobulina de uso subcutaneo.
US8304524B2 (en) 2009-07-23 2012-11-06 Baxter International Inc. Manufacture of factor H (FH) and FH-derivatives from plasma
MX2012003282A (es) 2009-09-17 2012-04-30 Baxter Healthcare Sa Co-formulacion estable de hialuronidasa e inmunoglobulina, y metodos de su uso.
WO2011150284A2 (fr) 2010-05-26 2011-12-01 Baxter International Inc. Élimination de sérine protéases par traitement avec du dioxyde de silicium finement divisé
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
SG187599A1 (en) 2010-07-23 2013-03-28 Baxter Int Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma
CA2810731A1 (fr) 2010-09-17 2012-03-22 Baxter International Inc. Stabilisation des immunoglobulines et autres proteines par des formulations aqueuses additionnees de chlorure de sodium a un ph faiblement acide a neutre
US9403899B2 (en) 2011-08-26 2016-08-02 Baxalta Incorporated Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
DK2820042T3 (da) 2012-02-29 2019-10-28 Baxalta GmbH Igg-stimuleret remyelinisering af perifere nerver
WO2025068923A2 (fr) 2023-09-26 2025-04-03 Takeda Pharmaceutical Company Limited Formulations d'immunoglobulines appauvries en iga

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
DE2856939A1 (de) * 1978-12-13 1980-07-03 Schura Blutderivate Gmbh & Co Verfahren zur gewinnung von intravenoes-vertraeglichen gammaglobulinen
JPS56113713A (en) * 1980-02-14 1981-09-07 Chemo Sero Therapeut Res Inst Preparation of immunoglobulin with high content of monomer
JPS5821611A (ja) * 1981-07-31 1983-02-08 スイス・レツド・クロス・ソサエテイ 血小板減少症治療剤
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
US4499073A (en) * 1981-08-24 1985-02-12 Cutter Laboratories, Inc. Intravenously injectable immune serum globulin
JPS5855432A (ja) * 1981-09-29 1983-04-01 Fujirebio Inc 静脈注射用免疫グロブリンの製法
US4437207A (en) * 1982-06-24 1984-03-20 Ross Henry M Magnetic, force-limited apparatus for tenderizing meat
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
AT383737B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur verwendung einer immunoglobulin-g enthaltenden fraktion
DK166763B1 (da) * 1983-03-16 1993-07-12 Immuno Ag Immunoglobulin-g-holdig fraktion
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
AT390560B (de) * 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern

Also Published As

Publication number Publication date
DK132284A (da) 1984-09-17
CA1245155A (fr) 1988-11-22
DK166763B1 (da) 1993-07-12
US5122373A (en) 1992-06-16
JPH0639388B2 (ja) 1994-05-25
EP0122909A1 (fr) 1984-10-24
DE3466542D1 (en) 1987-11-05
JPS601135A (ja) 1985-01-07
EP0122909B1 (fr) 1987-09-30
ATE30034T1 (de) 1987-10-15
DK132284D0 (da) 1984-02-29

Similar Documents

Publication Publication Date Title
DK166763C (da) Immunoglobulin-g-holdig fraktion
US4632980B1 (fr)
DE69535243D1 (de) Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
WO1994011026A3 (fr) Application therapeutique d'anticorps chimeriques et radio-marques contre l'antigene a differentiation restreinte des lymphocytes b humains pour le traitement du lymphome des cellules b
ATE157257T1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
ES2185695T3 (es) Terapia genica dirigida.
MY111196A (en) Therapeutic aplication of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
FI831230A0 (fi) N-glykosylerade karboxylsyraamidderivat, foerfarande foer deras framstaellning samt deras anvaendnifoer att paoverka kroppens eget foersvar
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
EP0308197A3 (fr) Méthode pour stimuler le système immunitaire
DK0562705T3 (da) Anvendelse af L-deprenyl til fremstilling af et lægemiddel til behandling af Cushings sygdom
KR880007088A (ko) 조직단백질 pp4를 함유하는 약제, pp4의 제조방법, 이의 저온살균법 및 용도
ES2176360T3 (es) Combinacion de vehiculos de administracion de genes.
EP0655888A4 (fr) Utilisation de porcs transgeniques pour la production d'hemoglobine humaine.
FI950144A0 (fi) Lysotsyymidimeeri ja sitä sisältävät koostumukset
DE3373978D1 (en) Composition for the care or treatment of the human skin
MX9804343A (es) Aplicacion dirigida de dosificaciones de agentes medicinales y terapeuticos y otros glicosaminoglicanos (gags).
DE3275060D1 (en) Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs
ATE63463T1 (de) Behandlung chronischer entzuendungskrankheiten.
WO1996032133A3 (fr) Conjugue pour le traitement de maladies inflammatoires, infectieuses et/ou dermiques
AU8459882A (en) Human leukocyte pepsin-like enzyme, and a therapeutic agent containing said enzyme as effective ingredient for treating allergic disorder, immune complex disease, and tumor
SU1069818A1 (ru) Способ профилактики гриппа
Mándi et al. The role of interferon in the adenovirus-induced augmentation of granulocyte-mediated cytotoxicity in chicken
RU93033105A (ru) Способ лечения острых вирусных заболеваний животных отряда псовых

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment
B1 Patent granted (law 1993)
PUP Patent expired